Based on the SMILES CNCCCN1c2ccccc2CCc2ccccc21, the molecule has a half life time in humans after IV administration of 22.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine